One of the things we are definitely doing is coming out with guidance for pharmaceutical firms that wish to bring forward tamper-proof formulations and be able to make a claim for tamper resistance. We actually are consulting. I don't have the date immediately top of mind, but certainly we're already out in the field with proposals around what criteria would have to be satisfied in order to be able to sustain a claim that something is tamper resistant. There are criteria you need to go through in order to be able to demonstrate from an evidence basis that something actually will be tamper proof and that people won't be able to defeat those features. Health Canada has been doing a lot of work to enable the pharma sector to come forward with those kinds of proposals.
We are doing a lot in the area of prescription drug abuse and particularly with regard to opioids. I would say a lot of the actions we've taken are very similar to those in the United States. We've certainly been talking to the Americans about the work we've been doing.
I'm happy to elaborate if there's an interest in it, but I know you don't have a lot of time.